Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea

Yum, Ho-Kee; Kim, Hak-Ryul; Soo Chang, Yoon; Shin, Kyeong-Cheol; Kim, Song; Oh, Yeon‐Mok

doi:10.4046/trd.2017.80.1.52

Public

Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea

Published in Tuberculosis & respiratory diseases • Jan 1, 2017

Authors:

Ho-Kee Yum

Hak-Ryul Kim

Yoon Soo Chang

Abstract

BACKGROUND: -agonist, is approved in over 100 countries, including South Korea, as a once-daily bronchodilator for maintenance and treatment of chronic obstructive pulmonary disease (COPD). Here, we present an interim analysis of a post-marketing surveillance study conducted to evaluate the real-wor...

Subject

Indacaterol

Medicine

COPD

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!